Impact of Pharmacogenetics on High-Dose Methotrexate Toxicity in Pediatric Oncology
<b>Background</b>: Childhood cancers represent a heterogeneous group of malignancies and remain one of the leading causes of mortality among children under 14 years of age, ranking second only to accidental injuries, and fourth among individuals aged 15 to 19 years. Despite notable impro...
Saved in:
| Main Authors: | Luciana Maria Marangoni-Iglecias, Almudena Sánchez-Martin, Laura Elena Pineda-Lancheros, Yasmín Cura, Noelia Marquez-Pete, José María Gálvez-Navas, Nerea Báez-Gutiérrez, Adrián Manuel de La Jara-Vera, Emilia Urrutia-Maldonado, Cristina Pérez-Ramírez, Alberto Jiménez-Morales |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-04-01
|
| Series: | Pharmaceutics |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1999-4923/17/5/585 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The pharmacogenetics antiepileptic drugs
by: N. A. Shnayder, et al.
Published: (2008-12-01) -
Pharmacogenetics of hypoglycemic agents
by: Irina Vladimirovna Kononenko, et al.
Published: (2015-12-01) -
Impact of pharmacogenetics on aspirin resistance: a systematic review
by: Gustavo Figueiredo da Silva, et al.
Published: (2023-01-01) -
Pharmacogenetics of chemical addictions
by: E. M. Krupitsky, et al.
Published: (2019-12-01) -
Pharmacogenetic Biomarkers of Ibrutinib Response and Toxicity in Chronic Lymphocytic Leukemia: Insights from an Observational Study
by: Noelia Pérez-Gómez, et al.
Published: (2025-07-01)